Bioventus Completes Divestiture of its Wound Business

May 23, 2023

https://www.globenewswire.com/news-release/2023/05/23/2674191/0/en/Bioventus-Completes-Divestiture-of-its-Wound-Business.html

DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq:BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has successfully completed the divestiture of its Wound business, including the skin substitutes TheraSkin and TheraGenesis, to LifeNet Health. The transaction, announced earlier this month, enables Bioventus’ improved focus on execution and delivers approximately $30 million of net closing proceeds, which will be used for debt repayment.

Read more at globenewswire.com

Related news for (BVS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.